Drug Profile
BSP 804
Alternative Names: BSP-804Latest Information Update: 28 Nov 2018
Price :
$50
*
At a glance
- Originator BioSource Pharm
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 28 Nov 2018 No recent reports of development identified for phase-I development in Bacterial-infections in USA
- 14 Oct 2015 Phase-I clinical trials in Bacterial infections in USA (unspecified route)
- 14 Oct 2015 Biosource completes phase I trial in Bacterial infections in USA before October 2015 (Biosource Pharm Pipeline, October 2015)